ClosedResearch announcementOpportunity HT942526AZRPTRRA

DoW Alzheimer’s Transforming Research Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Alzheimer’s Transforming Research Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was September 24, 2026. Total estimated funding is $4M across about 4 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

May 1, 2026Posted
Sep 24, 2026Application deadline
Oct 24, 2026Archivednext date

Posted: May 1, 2026
Close date: Sep 24, 2026
Archive date: Oct 24, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $4,000,000
Implied average award: $1,000,000 calculated
Expected awards: 4
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

Unrestricted (any entity type)

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD).

Distinctive Features:

• Applications must address at least one of the following focus areas:

○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here.

○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.

• Clinical research is allowed, however clinical trials and animal research are prohibited.

• Preliminary data are required.

• Community collaboration is required for research prospectively enrolling human subjects.

• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

FY26 AZRP TrRA Program AnnouncementFull Announcement · HT942526AZRPTrRA_GG.pdfPDF · 751 KB

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

JoAnn Martin Grantor
help@eBRAP.org
301-619-2594

Quick answers

Who is eligible to apply for “DoW Alzheimer’s Transforming Research Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Alzheimer’s Transforming Research Award”?

Per the notice, total estimated program funding is $4,000,000 and the agency expects to make about 4 awards.

How do I apply for “DoW Alzheimer’s Transforming Research Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526AZRPTRRA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

OpenResearchALN 12.420